(Q83961773)

English

Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials

scientific article published on 01 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

based on heuristic

inferred from title

author name string

Rui Fa Han

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jian Gang Pan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

67

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1216-1223

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Guidelines for reading case-control studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a nordic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guérin for superficial bladder cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Treatment of high-risk superficial bladder cancer with maintenance bacille Calmette-Guérin therapy: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Intravesical combined chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin is not indicated for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

The best management of superficial bladder tumours: comparing TUR alone versus TUR combined with intravesical chemotherapy modalities?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisati

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.014

7 January 2021

Identifiers

10.1016/J.UROLOGY.2005.12.014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765182%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83961773&oldid=1812251515"